Cargando…

Semaphorin Signaling in Cancer-Associated Inflammation

The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzolin, Giulia, Tamagnone, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358995/
https://www.ncbi.nlm.nih.gov/pubmed/30658382
http://dx.doi.org/10.3390/ijms20020377
_version_ 1783392120924536832
author Franzolin, Giulia
Tamagnone, Luca
author_facet Franzolin, Giulia
Tamagnone, Luca
author_sort Franzolin, Giulia
collection PubMed
description The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor cells, featuring an intense signaling cross-talk at local and systemic levels. Moreover, diverse semaphorins control both cells of the innate and the antigen-specific immunity. Notably, semaphorin signals acting as inhibitors of anti-cancer immune response are often dysregulated in human tumors, and may represent potential therapeutic targets. In this mini-review, we provide a survey of the best known semaphorin regulators of inflammatory and immune cells, and discuss their functional impact in the tumor microenvironment.
format Online
Article
Text
id pubmed-6358995
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63589952019-02-06 Semaphorin Signaling in Cancer-Associated Inflammation Franzolin, Giulia Tamagnone, Luca Int J Mol Sci Review The inflammatory and immune response elicited by the growth of cancer cells is a major element conditioning the tumor microenvironment, impinging on disease progression and patients’ prognosis. Semaphorin receptors are widely expressed in inflammatory cells, and their ligands are provided by tumor cells, featuring an intense signaling cross-talk at local and systemic levels. Moreover, diverse semaphorins control both cells of the innate and the antigen-specific immunity. Notably, semaphorin signals acting as inhibitors of anti-cancer immune response are often dysregulated in human tumors, and may represent potential therapeutic targets. In this mini-review, we provide a survey of the best known semaphorin regulators of inflammatory and immune cells, and discuss their functional impact in the tumor microenvironment. MDPI 2019-01-17 /pmc/articles/PMC6358995/ /pubmed/30658382 http://dx.doi.org/10.3390/ijms20020377 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Franzolin, Giulia
Tamagnone, Luca
Semaphorin Signaling in Cancer-Associated Inflammation
title Semaphorin Signaling in Cancer-Associated Inflammation
title_full Semaphorin Signaling in Cancer-Associated Inflammation
title_fullStr Semaphorin Signaling in Cancer-Associated Inflammation
title_full_unstemmed Semaphorin Signaling in Cancer-Associated Inflammation
title_short Semaphorin Signaling in Cancer-Associated Inflammation
title_sort semaphorin signaling in cancer-associated inflammation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358995/
https://www.ncbi.nlm.nih.gov/pubmed/30658382
http://dx.doi.org/10.3390/ijms20020377
work_keys_str_mv AT franzolingiulia semaphorinsignalingincancerassociatedinflammation
AT tamagnoneluca semaphorinsignalingincancerassociatedinflammation